Letters Attention-deficit/hyperactivity disorder

Reducing overdiagnosis and disease mongering in ADHD in Lombardy

BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f7474 (Published 16 December 2013) Cite this as: BMJ 2013;347:f7474
  1. Maurizio Bonati, head, Department of Public Health1,
  2. Laura Reale, research fellow1
  1. 1IRCCS—“Mario Negri” Pharmacological Research Institute, 20156 Milan, Italy
  1. maurizio.bonati{at}marionegri.it

In practice, clinicians’ subjectivity plays a role in mental health diagnosis1 and in the wide variation in prescription rates by country, region, and even in the same city.2 As Thomas and colleagues point out,3 practice guidelines on attention-deficit/hyperactivity disorder (ADHD) recommend performing a medical, psychosocial, and developmental evaluation to define severity, but leave it …

View Full Text

Log in

Log in through your institution


* For online subscription